Jane Street
CRDL

Jane Street’s Cardiol Therapeutics CRDL Stock Holding History

Jane Street’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.2K Buy
45,800
+2,800
+7% +$2.87K ﹤0.01% 10884
2025
Q4 		$41.1K Buy
+43,000
New +$45K ﹤0.01% 10560

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's CRDL Position: Q1 2026 in Review

Jane Street increased its Cardiol Therapeutics (CRDL) stake by 219% in Q1 2026, buying an estimated $89.4K and bringing the position to 126,957 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #10275.

Jane Street first reported a position in CRDL in Q3 2021 and has held it in 9 quarters since. The position peaked at $327K in Q3 2021. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Jane Street held 126,957 shares of Cardiol Therapeutics worth $172K as of Q1 2026.
  • Jane Street bought 87,129 Cardiol Therapeutics shares in Q1 2026, an estimated $89.4K.
  • Cardiol Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10275 holding.
  • Jane Street first reported a position in Cardiol Therapeutics in Q3 2021 and has held it in 9 quarters since.
  • Jane Street's Cardiol Therapeutics position peaked at $327K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.